Featured News

AIM Blog
Recognizing AIM’s June Advocate of the Month: Mike Razzi
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted by Alzheimer’s and all other dementia remain top-of-mind in Congres...
All News

Press Release
Alzheimer’s Association Statement on Donanemab Phase 3 Topline Data Release
Strongest Alzheimer's Phase 3 data release to date Association underscores urgent call for CMS to stop blocking access to FDA-approved...

AIM Blog
Recognizing AIM’s May Advocate of the Month: Priya Patel
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...

Press Release
Overwhelming Bipartisan Support for Access to FDA-Approved Alzheimer’s Treatments on Display in Health Subcommittee Hearing
Bipartisan members sharply question CMS Administrator why Alzheimer’s drugs aren’t reasonable and necessary Washington, D.C., April 26, 2023 — Today...

AIM Blog
Sign the Petition: Urge President Biden to Tell CMS to Stop Blocking Access to Alzheimer’s Treatments
For over a year, the Centers for Medicare & Medicaid Services (CMS) has been blocking access to Food and Drug...

AIM Blog
Alzheimer’s Advocates Are Demanding Access to FDA-Approved Alzheimer’s Treatments
In communities across the nation, Alzheimer’s Association advocates are building on the momentum from the AIM Advocacy Forum and calling...

AIM Blog
Recognizing AIM’s April Advocate of the Month: Belinda Jennings
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...